CNS disorders market
Posted: Mon Sep 21, 2020 5:19 am
A view into the central nervous system disorders market (2020)
https://www.nature.com/articles/d43747-020-01119-8
Top products
Therapies for multiple sclerosis (MS) accounted for 7 of the top 15 CNS products and 26% of CNS product sales in 2019—the highest market share, largely driven by products such as Biogen’s Tecfidera (dimethyl fumarate) and Roche’s Ocrevus (ocrelizumab). ...
https://www.nature.com/articles/d43747-020-01119-8
Top products
Therapies for multiple sclerosis (MS) accounted for 7 of the top 15 CNS products and 26% of CNS product sales in 2019—the highest market share, largely driven by products such as Biogen’s Tecfidera (dimethyl fumarate) and Roche’s Ocrevus (ocrelizumab). ...